Phototherapy has played a major role in the treatment of various skin diseases, including psoriasis, atopic dermatitis, and vitiligo.
1,2 Given the chronic and relapsing nature of such skin diseases, patients often receive multiple courses of phototherapy during their lives. There have been concerns about whether repetitive exposure to UV light during long-term phototherapy would increase the risk of photocarcinogenesis
3 because UV is well known to cause nonmelanoma skin cancers (NMSCs) and melanoma.
3,4 Among the various types of phototherapy, psoralen plus UV-A (PUVA) phototherapy has been found to be associated with an increased risk of skin cancers,
5-7 but it is not currently widely used. The widespread use of indoor tanning has raised concerns about an increased risk of skin cancer and many dermatologists are strongly opposed to indoor tanning.
8 However, to our knowledge, the risk of skin cancer after long-term narrowband UV-B (NBUVB) phototherapy, which is now widely used for therapeutic purposes in dermatology, has not been fully investigated.
5,9,10